Form 4: HCA Healthcare Director Robert J. Dennis Acquires Shares Through Equity Award and Retainer
SEC Form 4 Filing
Director Robert J. Dennis acquired 963 shares of HCA Healthcare, Inc. common stock on April 29, 2024, through an equity award and in lieu of a cash retainer.
Summary
- On April 29, 2024, Robert J. Dennis, a director of HCA Healthcare, Inc., acquired 963 shares of common stock.
- These shares were obtained through an annual director equity award (610 shares) and in lieu of an annual cash retainer for service as a director (353 shares).
- The restricted share units will vest on the earlier of the date of the 2025 annual shareholders' meeting or the first anniversary of the grant date.
- Vested shares will be delivered when Dennis ceases to be a member of the Board of Directors.
- Following the transaction, Dennis directly owns 25,575 shares of HCA Healthcare, Inc.
- Robert J. Dennis has a Power of Attorney agreement designating John M. Franck II, Natalie Harrison Cline, and Kevin A. Ball as attorneys-in-fact.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't contain information that would significantly sway investor sentiment positively or negatively.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The restricted share units will vest on the sooner of the date of the 2025 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date, and vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. Directors often receive stock as part of their compensation.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder confidence due to the director's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 2014-01-31 | Date of Power of Attorney execution. |
| 2024-04-29 | Date of stock acquisition. |
| 2024-05-01 | Date of signature for the Form 4 filing. |
| 2025 | Restricted share units vest on the sooner of the date of the 2025 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.